Current PCa markers such as PSA, PCA3, TMPRSS2-ERG, and PSMA are expressed in PCa cells, but some of them are differently expressed depending on the location even in the same tumor from the same patient, complicating the implementation of a general therapy. This evidence concerns the gene FOLH1 and neoplasm.